-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Protalix BioTherapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2010 to 2023.
- Protalix BioTherapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -38.9 %, a 312% decline year-over-year.
- Protalix BioTherapeutics, Inc. annual Operating Margin for 2023 was 16 %.
- Protalix BioTherapeutics, Inc. annual Operating Margin for 2022 was -27.3 %, a 48.8% increase from 2021.
- Protalix BioTherapeutics, Inc. annual Operating Margin for 2021 was -53.4 %, a 1338% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)